FDA Recalls Accula SARS-CoV-2 Test for False Positive Risk
Mesa Biotech is recalling approximately 6,162 units of the Accula SARS-CoV-2 Test due to an increased risk of false positive results, which could delay correct diagnosis and treatment.
- Product
- Accula SARS-CoV-2 Test, REF: COV4100
- Category
- Medical Device
- Distribution
- Distributed nationwide